White House Unwraps Massive Drug Pricing Policy, Touching All Corners of Pharma

The package revives President Donald Trump’s much-maligned Most Favored Nations rule but goes further into the private markets and beyond, leveraging the patent system, drug importation and more.

Scroll to Top